The European Commission has launched the first call for medicinal products for Joint Scientific Consultations (JSC) on behalf of the HTACG. JSCs offer HTDs the opportunity to seek advice on the technology from HTA bodies. The HTACG will conduct up to 10 JSCs in 2025 and look to increase capacity in the following years. Application period closes 3rd March 2025.
For more information: https://health.ec.europa.eu/health-technology-assessment/implementation-regulation-health-technology-assessment/joint-scientific-consultations_en
